Parkman Healthcare Partners’s Zymeworks ZYME Stock Holding History

Parkman Healthcare Partners’s Portfolio ZYME Stock Details ZYME Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell
2022 Q2	$667K	Buy
2022 Q1	$781K	Buy
2021 Q4	$682K	Buy
2021 Q3	$871K	Buy
2020 Q4	–	Sell
2020 Q3	$3.96M	Buy